How many insider trades does FilingIQ track for ADIL?

FilingIQ tracks 66 Form 4 insider transactions for ADIL (ADIAL PHARMACEUTICALS, INC.), covering filings from Jul 31, 2018 onwards. 6 of those were filed in the last 90 days.

Are ADIL insiders net buyers or net sellers?

Across the full Form 4 history for ADIL, 24 transactions (36%) were open-market purchases and 4 (6%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ADIL insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ADIL in?

ADIAL PHARMACEUTICALS, INC. (ADIL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $2.23M.

ADIL insider trading

NasdaqCM Healthcare

ADIAL PHARMACEUTICALS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

36% / 6%

Market cap

$2.23M

About ADIAL PHARMACEUTICALS, INC.

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.

Company website: www.adial.com

ADIL insider activity at a glance

FilingIQ has scored 66 insider transactions for ADIL since Jul 31, 2018. The most recent filing in our index is dated Apr 7, 2026.

Across the full history, 24 open-market purchases and 4 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ADIL insider trades is 61.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ADIL trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ADIL?: FilingIQ tracks 66 Form 4 insider transactions for ADIL (ADIAL PHARMACEUTICALS, INC.), covering filings from Jul 31, 2018 onwards. 6 of those were filed in the last 90 days.
Are ADIL insiders net buyers or net sellers?: Across the full Form 4 history for ADIL, 24 transactions (36%) were open-market purchases and 4 (6%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ADIL insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ADIL in?: ADIAL PHARMACEUTICALS, INC. (ADIL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $2.23M.

Methodology & sources

Every ADIL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.